The impact of Endocuff-assisted colonoscopy on adenoma detection in an organized screening program

Abstract

Background and study aims Colorectal cancer (CRC) screening with biennial fecal occult blood test has been shown to reduce CRC mortality. For the effectiveness of the CRC screening program is crucial that a high-quality colonoscopy with a high adenoma detection rate (ADR) be performed. To improve ADR, various endoscopic devices have been developed. Endocuff, an endoscopic cap with finger-like projections, has been shown to improve ADR. The aim of this study was to compare in an organized CRC screening program ADR, advanced adenoma detection rate (AADR) and mean number of adenomas per patient (MAP) using standard colonoscopy (SC) and Endocuff-assisted colonoscopy (EAC).

Patients and methods We compared performance of SC (in 2014) and EAC (in 2015) in consecutive participants in an organized CRC screening program.

Results SC and EAC were performed in 546 (284 males) and 519 (293 males) subjects, respectively (mean age 60 years). Cecal intubation rate was 97.4 % for SC and 97.1 % for EAC and not significantly different (P = 0.7). ADR was 47 % for SC and 52 % for EAC, P = 0.1. MAP in SC and EAC were 0.87 (range: 0 – 7) and 1.11 (range: 0 – 13) respectively, P = 0.02. AADR rate was 25 % and 23 % for SC and EAC, respectively, P = 0.5.

Conclusion Endocuff-assisted colonoscopy does not improve the number of patients with at least one adenoma but it may increase the number of detected adenomas per procedure.

• References

• 1 Ferlay J, Autier P, Boniol M. et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592
• 2 Mandel JS, Bond TH, Church TR. et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993; 328: 1365-1371
• 3 Hardcasle JD, Chamberlain LO, Robinson MHE. et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
• 4 Zorzi M, Fedeli U, Schievano E. et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2015; 64: 784-790
• 5 Zorzi M, Fedato C, Del Sole A. et al. I programmi di screening oncologici del Veneto. Rapporto 2013–2014.. 1st. ed. Padova: CLEUP; 2015
• 6 Hassan C, Repici A, Rex DK. FITting ADR to colonoscopy indication. United European Gastroenterol J 2017; 5: 149-152
• 7 Rex DK, Schoenfeld PS, Cohen J. et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015; 81: 31-53
• 8 Corley DA, Jensen CD, Marks AR. et al. Adenoma detection rate and risk of interval cancer. N Engl J Med 2014; 370: 1298-1306
• 9 Konda V, Chauhan SS, Abu Dayyeh Barham K. et al. Endoscopes and devices to improve colon polyp detection. Gastrointest Endosc 2015; 81: 1122-1129
• 10 Lenze F, Beyna T, Lenz P. et al. Endocuff-assisted colonoscopy: a new accessory to improve adenoma detection rate? Technical aspects and first clinical experience. Endoscopy 2014; 46: 610-614
• 11 Biecker E, Floer M, Heinecke A. et al. Novel Endocuff-assisted colonoscopy significantly increases the polyp detection rate: a randomized controlled trial. J Clin Gastroenterol 2015; 49: 413-418
• 12 Floer M, Biecker E, Fitzlaff R. et al. Higher adenoma detection rates with Endocuff-assisted colonoscopy – a randomized controlled multicenter trial. PLoS One 2014; 9: e114267
• 13 Van Doorn SC, van der Vlugt M, Depla A. et al. Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomized controlled trial. Gut 2017; 66: 438-445
• 14 Bhattacharyya R, Chedgy F, Kandiah K. et al. Endocuff-assisted vs. standard colonoscopy in the fecal occult blood test-based UK Bowel Cancer Screening Programme (E-cap study): a randomized trial. Endoscopy 2017; 49: 1043-1050
• 15 González-Fernández C, García-Rangel D, Aguilar-Olivos NE. et al. Higher adenoma detection rate with the endocuff: a randomized trial. Endoscopy 2017; 49: 1061-1068
• 16 Triantafyllou K, Polymeros D, Apostolopoulos P. et al. Endocuff-assisted colonoscopy is associated with a lower adenoma miss rate: a multicenter randomized tandem study. Endoscopy 2017; 49: 1051-1060
• 17 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-S43
• 18 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
• 19 Zorzi M, Senore C, Da Re F. et al. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut 2015; 64: 1389-1396
• 20 Kahi CJ, Vemulapalli KC, Johnson CS. Improving measurement of the adenoma detection rate and adenoma per colonoscopy quality metric: the Indiana University experience. Gastrointest Endosc 2014; 79: 448-454
• 21 Faul F, Erdfelder E, Lang AG. et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191
• 22 Wang HS, Pisegna J, Modi R. et al. Adenoma detection rate is necessary but insufficient for distinguishing high versus low endoscopist performance. Gastrointest Endosc 2013; 77: 71-78
• 23 Denis B, Sauleau EA, Gendre I. Measurement of adenoma detection and discrimination during colonoscopy in routine practice: an exploratory study. Gastrointest Endosc 2011; 74: 1325-1336
• 24 Atkin WS, Valori R, Kuipers EJ. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Colonoscopic surveillance following adenoma removal. Endoscopy 2012; 44: 151-163
• 25 Kahi CJ, Hewett DG, Norton DL. et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9: 42-46